Option Care Health saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 98.
Lean How — And When — To Sell Stocks
The new score indicates the company is now outperforming 98% of all stocks in terms of the most important fundamental and technical stock-picking criteria. Winning stocks often have a 95 or higher grade in the early stages of a new price run, so that's a good item to have on your checklist when looking for the best stocks to buy and watch.
Option Care Health broke out earlier, but is now around -5% below the 35.57 buy point from a consolidation. See if the stock can climb back into the buy zone in heavy volume.
The stock earns a 93 EPS Rating, meaning its recent quarterly and annual earnings growth is outpacing 93% of all stocks.
Its Accumulation/Distribution Rating of C- shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
The company reported 14% earnings growth for Q1. Top line growth came in at 16%, down from 20% in the prior quarter.
Option Care Health holds the No. 2 rank among its peers in the Medical-Services industry group. Hims & Hers Health is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
